Implications of Extra-cardiac Disease in Patient Selection for Heart Transplantation: Considerations in Cardiac Amyloidosis

Disease-modifying therapies in both light chain and transthyretin amyloidosis have improved patient functional status and survival. Conceivably, as heart failure may progress despite amyloid therapies, more patients may be considered for heart transplantation. In earlier eras, extra-cardiac amyloid...

Descripción completa

Detalles Bibliográficos
Autores principales: Punnoose, Lynn Raju, Siddiqi, Hasan, Rosenthal, Julie L, Kittleson, Michelle, Witteles, Ronald, Alexander, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2023
Materias:
New Advances in Heart Failure
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987512/
https://www.ncbi.nlm.nih.gov/pubmed/36891177
http://dx.doi.org/10.15420/cfr.2022.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987512/
https://www.ncbi.nlm.nih.gov/pubmed/36891177
http://dx.doi.org/10.15420/cfr.2022.24

Ejemplares similares